Latest News
Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals, Inc. Estimates – MUN:9EP
- Enanta announces October 22 RSV data presentation for Enanta Pharmaceuticals stock
- H.C. Wainwright keeps USD 20.00 target for Enanta Pharmaceuticals stock
- Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at IDWeek™ 2026
- Enanta Pharmaceuticals (ENTA) Climbs 2.14% as Shares Test Upper Range - Spring Pattern
- Enanta Pharmaceuticals (ENTA) Ticks Up 0.93% to $12.96 as Shares Sit Mid-Range Between Key Levels - Stock News
- Enanta sheds staffers as key antiviral, immunology readouts loom
Headlines from the last 30 days, linking to the original publishers. See all market news →